Promising developments bringing prion diseases closer to therapy and prophylaxis

被引:11
作者
Gilch, S [1 ]
Schätzl, HM [1 ]
机构
[1] Tech Univ Munich, Inst Virol, Prion Res grp, D-80802 Munich, Germany
关键词
D O I
10.1016/S1471-4914(03)00144-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prion diseases are fatal, infectious, neurodegenerative disorders, and there are no available therapeutic or prophylactic regimens. The potential of immune system components in combating peripheral prion infection has long been underestimated, but recent studies have suggested that such molecules could be effective. For example, promising results have been reported from a passive vaccination study in prion-infected mice. In addition, elegant transgenic mouse studies have shown the inhibitory effect on prion propagation of a soluble immunoglobulin G (IgG)-like dimeric prion protein. This type of molecule might represent a new class of antiprion compounds.
引用
收藏
页码:367 / 369
页数:3
相关论文
共 26 条
[1]   The molecular biology of prion propagation [J].
Clarke, AR ;
Jackson, GS ;
Collinge, J .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 2001, 356 (1406) :185-194
[2]   STRUCTURAL CLUES TO PRION REPLICATION [J].
COHEN, FE ;
PAN, KM ;
HUANG, Z ;
BALDWIN, M ;
FLETTERICK, RJ ;
PRUSINER, SB .
SCIENCE, 1994, 264 (5158) :530-531
[3]   A KINETIC-MODEL FOR AMYLOID FORMATION IN THE PRION DISEASES - IMPORTANCE OF SEEDING [J].
COME, JH ;
FRASER, PE ;
LANSBURY, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) :5959-5963
[4]   Predictability of the UK variant Creutzfeldt-Jakob disease epidemic [J].
d'Aignaux, JNH ;
Cousens, SN ;
Smith, PG .
SCIENCE, 2001, 294 (5547) :1729-1731
[5]   Immunotherapy for Alzheimer's disease: will vaccination work? [J].
Dodart, JC ;
Bales, KR ;
Paul, SM .
TRENDS IN MOLECULAR MEDICINE, 2003, 9 (03) :85-87
[6]   Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody [J].
Enari, M ;
Flechsig, E ;
Weissmann, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) :9295-9299
[7]   Polyclonal anti-PrP auto-antibodies induced with dimeric PrP interfere efficiently with PrPSc propagation in prion-infected cells [J].
Gilch, S ;
Wopfner, F ;
Renner-Müller, I ;
Kremmer, E ;
Bauer, C ;
Wolf, E ;
Brem, G ;
Groschup, MH ;
Schätzl, HM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (20) :18524-18531
[8]   Intracellular re-routing of prion protein prevents propagation of PrPSc and delays onset of prion disease [J].
Gilch, S ;
Winklhofer, KF ;
Groschup, MH ;
Nunziante, M ;
Lucassen, R ;
Spielhaupter, C ;
Muranyi, W ;
Riesner, D ;
Tatzelt, J ;
Schätzl, HM .
EMBO JOURNAL, 2001, 20 (15) :3957-3966
[9]   Inhibition of prion-protein conversion: a therapeutic tool? [J].
Head, MW ;
Ironside, JW .
TRENDS IN MICROBIOLOGY, 2000, 8 (01) :6-8
[10]   Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies [J].
Heppner, FL ;
Musahl, C ;
Arrighi, I ;
Klein, MA ;
Rülicke, T ;
Oesch, B ;
Zinkernagel, RM ;
Kalinke, U ;
Aguzzi, A .
SCIENCE, 2001, 294 (5540) :178-182